FTIR spectra of MUCG at different curing age. by Junxia Zhou (14381598)

Subjects:

Mediation analysis. by Vincenza Tarantino (182506)

Subjects:

Description of fitting models. by Junxia Zhou (14381598)

Subjects:

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

Subjects:

LUC in southeast Yunnan under different scenarios in 2035. by Bao Zhou (20670850)

Subjects:

Mineral composition of UFC, B, and SF. by Junxia Zhou (14381598)

Subjects:

Spearman’s correlation coefficients between mean scores of each S-Hab-Q factor and the AQ subscales. by Vincenza Tarantino (182506)

Subjects:

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

Subjects:

Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

Subjects:

Distribution of ESs and hot and cold spots during the historical period. by Bao Zhou (20670850)

Subjects:

Spatial distribution of ESs. by Bao Zhou (20670850)

Subjects:

Fig 8 - by Junxia Zhou (14381598)

Subjects:

Correspondence of support for SDGs across ESs categories. by Bao Zhou (20670850)

Subjects:

Data Sheet 1_Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database.docx by Huiling Zhang (396342)

“…Common preferred terms were identified, including diarrhea, fatigue, death, nausea, platelet count decreased, and hemoglobin decreased. Notably, 26 off­-label AEs were also identified.…”

Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

Subjects:

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects: